Expecting 15% Revenue Growth in FY16: Dishman Pharma
PUBLISHED ON: February 6, 2015 | Duration: 8 min, 39 sec
Arpit Vyas, managing director at Dishman Pharmaceuticals and Chemicals, told NDTV that it has added 10-15 small and mid-sized biotech companies which will contribute to the revenue growth next financial year.
